Schoenmakers Karin P W, Fenten Maaike G E, Louwerens Jan Willem, Scheffer Gert Jan, Stienstra Rudolf
Department of Anaesthesiology, Post box 9011, 6500 GM, Nijmegen, The Netherlands.
Department of Anaesthesiology, Radboud University Medical Center, Nijmegen, The Netherlands.
BMC Anesthesiol. 2015 Jul 10;15:100. doi: 10.1186/s12871-015-0083-z.
Duration of peripheral nerve blocks depends on multiple factors. Both technique and type of local anesthetic used, either with or without adjuncts, may result in different duration times of the block. The purpose of the present study was to compare the duration of postoperative analgesia of 30 mL ropivacaine 0.75 % with or without epinephrine for popliteal sciatic nerve block.
Thirty-eight patients were included to receive ultrasound guided continuous popliteal nerve block with ropivacaine 0.75 % either without (ROPI) or with epinephrine 5 μg/mL (ROPI-EPI) for ankle fusion, subtalar fusion, or a combination of both. The primary outcome parameter was the duration of postoperative analgesia as reflected by the time to first request for postoperative analgesia (TTFR) through the popliteal nerve catheter. Secondary outcome measures included the onset of sensory and motor block and NRS score for pain at rest and during movement.
Thirty patients, 15 in each group, were studied. Eight patients were withdrawn because of specific withdrawal criteria described in the protocol and replaced according to their group allocation. Median [interquartile range] TTFR was 463 [300-1197] min and 830 [397-1128] min for the ROPI vs ROPI-EPI group respectively. Hodges Lehman median difference between groups was 71 min (95 % CI -415 - 473 min). There was no difference in any clinical outcome measure between the groups.
The results of this study did not show any significant increase in the duration of postoperative analgesia by adding epinephrine to ropivacaine for popliteal nerve block. This may be due to the intrinsic vasoconstrictive properties of ropivacaine. The absence of a significant difference can also be the result of a type II error caused by a large variation in the individual TTFR.
Trial register.nl identifier: NTR3330 , keyword TTFR.
外周神经阻滞的持续时间取决于多种因素。所用局部麻醉药的技术和类型,无论是否使用辅助药物,都可能导致不同的阻滞持续时间。本研究的目的是比较30 mL 0.75%罗哌卡因在有或无肾上腺素情况下用于腘部坐骨神经阻滞的术后镇痛持续时间。
纳入38例患者,接受超声引导下连续腘部神经阻滞,使用0.75%罗哌卡因,其中一组不添加肾上腺素(ROPI),另一组添加5 μg/mL肾上腺素(ROPI-EPI),用于踝关节融合、距下关节融合或两者联合手术。主要结局参数是术后镇痛持续时间,通过腘部神经导管首次要求术后镇痛的时间(TTFR)来反映。次要结局指标包括感觉和运动阻滞的起效时间以及静息和运动时疼痛的NRS评分。
共研究了30例患者,每组15例。8例患者因方案中描述的特定退出标准退出,并根据其分组分配进行替换。ROPI组和ROPI-EPI组的TTFR中位数[四分位间距]分别为463[300 - 1197]分钟和830[397 - 1128]分钟。两组之间的霍奇斯·莱曼中位数差异为71分钟(95%CI -415 - 473分钟)。两组在任何临床结局指标上均无差异。
本研究结果未显示在腘部神经阻滞中向罗哌卡因添加肾上腺素会使术后镇痛持续时间有任何显著增加。这可能是由于罗哌卡因本身的血管收缩特性。无显著差异也可能是由于个体TTFR差异较大导致的II类错误的结果。
Trial register.nl标识符:NTR3330,关键词TTFR